Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
Buy
74
ESLT Quote, Financials, Valuation and Earnings
Last price:
$257.78
Seasonality move
:
4.43%
Day range:
$255.01 - $258.46
52-week range:
$175.30 - $266.35
Dividend yield:
0.77%
P/E ratio:
44.18x
P/S ratio:
1.77x
P/B ratio:
3.75x
Volume:
28.4K
Avg. volume:
42.4K
1-year change:
20.5%
Market cap:
$11.5B
Revenue:
$6B
EPS (TTM):
$5.85
Analysts' Opinion
-
Consensus RatingElbit Systems has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Elbit Systems has an estimated upside of 2.17% from its current price of $258.46.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $258.46.
Fair Value
-
According to the consensus of 0 analysts, Elbit Systems has 2.17% upside to fair value with a price target of -- per share.
ESLT vs. S&P 500
-
Over the past 5 trading days, Elbit Systems has underperformed the S&P 500 by -1.56% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Elbit Systems does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Elbit Systems has grown year-over-year revenues for 8 quarters straight. In the most recent quarter Elbit Systems reported revenues of $1.7B.
Earnings Growth
-
Elbit Systems has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Elbit Systems reported earnings per share of $1.77.
Enterprise value:
12.5B
EV / Invested capital:
3.01x
Price / LTM sales:
1.77x
EV / EBIT:
34.15x
EV / Revenue:
1.91x
PEG ratio (5yr expected):
--
EV / Free cash flow:
62.26x
Price / Operating cash flow:
57.67x
Enterprise value / EBITDA:
23.80x
Gross Profit (TTM):
$1.6B
Return On Assets:
2.56%
Net Income Margin (TTM):
4%
Return On Equity:
8.76%
Return On Invested Capital:
6.41%
Operating Margin:
7.33%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $5.5B | $5.9B | $6.5B | $1.5B | $1.7B | |
| Gross Profit | $1.4B | $1.5B | $1.6B | $367.2M | $412.8M | |
| Operating Income | $342.7M | $417.3M | $408.6M | $106.1M | $125.8M | |
| EBITDA | $502.4M | $553.2M | $523.2M | $146.9M | $171.8M | |
| Diluted EPS | $4.45 | $6.07 | $5.85 | $1.36 | $1.77 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $4.1B | $4.9B | $5.2B | $5.4B | $6.4B | |
| Total Assets | $7.7B | $9.2B | $9.5B | $9.6B | $10.8B | |
| Current Liabilities | $3.3B | $3.9B | $4.5B | $4.8B | $5.5B | |
| Total Liabilities | $5.5B | $6.7B | $6.8B | $6.8B | $7.8B | |
| Total Equity | $2.3B | $2.5B | $2.6B | $2.8B | $3.1B | |
| Total Debt | $867M | $1.1B | $1B | $1.2B | $1.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $304.6M | -$4.6M | $396.3M | $10.7M | $56.5M | |
| Cash From Investing | -$149.2M | -$268.5M | -$148.2M | -$62.4M | -$20.7M | |
| Cash From Financing | -$110.3M | $145.2M | -$249.1M | $60.3M | -$37.3M | |
| Free Cash Flow | $43.5M | -$179.1M | $200M | -$49.9M | $5.1M | |
ESLT
Sector
Market Cap
$11.5B
$770.7M
Price % of 52-Week High
97.04%
79.02%
Dividend Yield
0.77%
0%
Shareholder Yield
1.17%
2.31%
1-Year Price Total Return
20.5%
-1.97%
Beta (5-Year)
0.526
0.898
Dividend yield:
0.77%
Annualized payout:
$2.00
Payout ratio:
34.05%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$260.02
200-day SMA
Buy
Level
$206.14
Bollinger Bands (100)
Buy
Level
194.38 - 242.82
Chaikin Money Flow
Sell
Level
-884.4K
20-day SMA
Buy
Level
$253.11
Relative Strength Index (RSI14)
Buy
Level
59.28
ADX Line
Sell
Level
20.33
Williams %R
Neutral
Level
-34.5447
50-day SMA
Buy
Level
$239.40
MACD (12, 26)
Buy
Level
6.06
25-day Aroon Oscillator
Buy
Level
44
On Balance Volume
Neutral
Level
8.6M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (1.9967)
Sell
CA Score
(Annual)
Level (-0.9881)
Buy
Beneish M-Score
(Annual)
Level (-2.6356)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (0.8877)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Elbit Systems Ltd is a technology company involved in producing a portfolio of systems and products for aircraft, land, and naval applications. The company's products are primarily used for defense, homeland security, and commercial flight capabilities. Its systems and solutions may be installed on new platforms, or it may perform a comprehensive modernization program to transform a platform. Elbit Systems gives instructions to its customers on proper maintenance of its products and will provide support team specialists when the customer cannot fix a problem. The company markets its systems and products as a prime contractor or as a subcontractor to government, defense, and homeland security contractors worldwide.
Stock Forecast FAQ
In the current month, ESLT has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ESLT average analyst price target in the past 3 months is --.
-
Where Will Elbit Systems Stock Be In 1 Year?
According to analysts, the consensus estimate is that Elbit Systems share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Elbit Systems?
Analysts are divided on their view about Elbit Systems share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Elbit Systems is a Sell and believe this share price will drop from its current level to --.
-
What Is Elbit Systems's Price Target?
The price target for Elbit Systems over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ESLT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Elbit Systems is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of ESLT?
You can purchase shares of Elbit Systems via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Elbit Systems shares.
-
What Is The Elbit Systems Share Price Today?
Elbit Systems was last trading at $257.78 per share. This represents the most recent stock quote for Elbit Systems. Yesterday, Elbit Systems closed at $258.46 per share.
-
How To Buy Elbit Systems Stock Online?
In order to purchase Elbit Systems stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is down 3.22% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 4.72% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is down 4.82% over the past day.
